221 related articles for article (PubMed ID: 18327819)
1. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features.
Mandal M; Myers JN; Lippman SM; Johnson FM; Williams MD; Rayala S; Ohshiro K; Rosenthal DI; Weber RS; Gallick GE; El-Naggar AK
Cancer; 2008 May; 112(9):2088-100. PubMed ID: 18327819
[TBL] [Abstract][Full Text] [Related]
2. Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expression.
Umbreit C; Flanjak J; Weiss C; Erben P; Aderhold C; Faber A; Stern-Straeter J; Hoermann K; Schultz JD
Anticancer Res; 2014 Dec; 34(12):7061-9. PubMed ID: 25503133
[TBL] [Abstract][Full Text] [Related]
3. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.
Usami Y; Satake S; Nakayama F; Matsumoto M; Ohnuma K; Komori T; Semba S; Ito A; Yokozaki H
J Pathol; 2008 Jul; 215(3):330-9. PubMed ID: 18491351
[TBL] [Abstract][Full Text] [Related]
4. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
Wang L; Jia Y; Jiang Z; Gao W; Wang B
Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
[TBL] [Abstract][Full Text] [Related]
5. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
[TBL] [Abstract][Full Text] [Related]
6. Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas.
Veracini L; Grall D; Schaub S; Beghelli-de la Forest Divonne S; Etienne-Grimaldi MC; Milano G; Bozec A; Babin E; Sudaka A; Thariat J; Van Obberghen-Schilling E
Oncotarget; 2015 Apr; 6(10):7570-83. PubMed ID: 25779657
[TBL] [Abstract][Full Text] [Related]
7. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition.
Nguyen PT; Kudo Y; Yoshida M; Kamata N; Ogawa I; Takata T
Histol Histopathol; 2011 Feb; 26(2):147-56. PubMed ID: 21154228
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
[TBL] [Abstract][Full Text] [Related]
10. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949
[TBL] [Abstract][Full Text] [Related]
11. The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1.
Nguyen PT; Tsunematsu T; Yanagisawa S; Kudo Y; Miyauchi M; Kamata N; Takata T
Br J Cancer; 2013 Oct; 109(8):2248-58. PubMed ID: 24045665
[TBL] [Abstract][Full Text] [Related]
12. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma.
Cappellesso R; Marioni G; Crescenzi M; Giacomelli L; Guzzardo V; Mussato A; Staffieri A; Martini A; Blandamura S; Fassina A
Histopathology; 2015 Oct; 67(4):491-500. PubMed ID: 25684546
[TBL] [Abstract][Full Text] [Related]
14. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression.
Liu X; Feng R
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):496-501. PubMed ID: 20705589
[TBL] [Abstract][Full Text] [Related]
16. [Effect of plumbagin on epithelial-mesenchymal transition and underlying mechanisms in human tongue squamous cell carcinoma cells].
Li B; Pan ST; Qiu JX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Jul; 52(7):421-426. PubMed ID: 29972906
[No Abstract] [Full Text] [Related]
17. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
18. Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition.
Sun Q; Prasad R; Rosenthal E; Katiyar SK
BMC Complement Altern Med; 2011 Dec; 11():134. PubMed ID: 22188922
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.
Prudkin L; Liu DD; Ozburn NC; Sun M; Behrens C; Tang X; Brown KC; Bekele BN; Moran C; Wistuba II
Mod Pathol; 2009 May; 22(5):668-78. PubMed ID: 19270647
[TBL] [Abstract][Full Text] [Related]
20. N-cadherin expression is correlated with metastasis of spindle cell carcinoma of head and neck region.
Nguyen PT; Kudo Y; Yoshida M; Iizuka S; Ogawa I; Takata T
J Oral Pathol Med; 2011 Jan; 40(1):77-82. PubMed ID: 21070371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
